[1. Aisner D.L., Maker A., Rosenberg S.A., Berman D.M.: Loss of S100 antigenicity in metastatic melanoma. Hum Pathol 2005, 36, 1016–1019.10.1016/j.humpath.2005.07.010265636516153466]Search in Google Scholar
[2. Azumi N., Battifora H.: The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol 1987, 88, 286–296.10.1093/ajcp/88.3.2862443000]Search in Google Scholar
[3. Barak V., Goike H., Panaretakis K.W., Einarsson R.: Clinical utility of cytokeratins as tumor markers. Clin Biochem 2004, 37, 529–540.10.1016/j.clinbiochem.2004.05.00915234234]Search in Google Scholar
[4. Burrai G.P., Tanca A., De Miglio M.R., Abbondio M., Pisanu S., Polinas M., Pirino S., Mohammed S.I., Uzzau S., Addis M.F., Antuofermo E.: Investigation of HER2 expression in canine mammary tumors by antibody–based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer? Tumour Biol 2015, 36, 9083–9091.10.1007/s13277-015-3661-226088453]Search in Google Scholar
[5. Cai W., Chen K., Mohamedali K.A., Cao Q., Gambhir S.S., Rosenblum M.G., Chen X.: PET of vascular endothelial growth factor receptor expression. J Nucl Med 2006, 47, 2048–2056.]Search in Google Scholar
[6. Campos A.G., Campos J.A.D.B., Sanches D.S., Dagli M.L.Z., Matera J.M.: Immunohistochemical evaluation of vascular endothelial growth factor (VEGF) in splenic hemangiomas and hemangiosarcomas in dogs. Open J Vet Med 2012, 2, 191–195. doi:10.4236/ojvm.2012.24030.10.4236/ojvm.2012.24030]Search in Google Scholar
[7. Ermert L., Dierkes C., Ermert M.: Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors. Clin Cancer Res 2003, 9, 1604–1610.]Search in Google Scholar
[8. Fetsch P.A., Abati A.: Overview of the clinical immunohistochemistry laboratory: Regulations and troubleshooting guidelines. Methods Mol Biol 1999, 115, 405–414.10.1385/1-59259-213-9:405]Search in Google Scholar
[9. Fuchs S.Y., Ougolkov A.V., Spiegelman V.S., Minamoto T.: Oncogenic beta-catenin signaling networks in colorectal cancer. Cell Cycle 2005, 4, 1522–1539.10.4161/cc.4.11.212916258275]Search in Google Scholar
[10. Galus R., Włodarski K.: Cytokeratin detection as a diagnostic tool in oncology. Pol Merk Lek 2007, 135, 209–211.]Search in Google Scholar
[11. Hara S., Kamei D., Sasaki Y., Tanemoto A., Nakatani Y., Murakami M.: Prostaglandin E synthases: understanding their pathophysiological roles through mouse genetic models. Biochimie 2010, 2, 651–649.10.1016/j.biochi.2010.02.00720159030]Search in Google Scholar
[12. Hu W.Q., Peng C.W., Li Y.: The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance–associated protein in gastric cancer. J Exp Clin Cancer Res 2009, 28, 144.10.1186/1756-9966-28-144278853619930704]Search in Google Scholar
[13. Illera J.V., Perez-Alenza M.D., Nieto A., Jimenez M.A., Silvan G., Dunner S., Peña L.: Steroid and receptors in canine mammary cancer. Steroids 2006, 71, 541–548.10.1016/j.steroids.2005.11.00716631217]Search in Google Scholar
[14. Inoue M., Wada N.: Immunohistochemical detection of p53 and p21 proteins in canine testicular tumours. Vet Rec 2000, 146, 370–372.10.1136/vr.146.13.370]Search in Google Scholar
[15. Janneh O., Anwar T., Jungbauer C., Kopp S., Khoo S.H., Back D.J., Chiba P.: P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir. Antivir Therap 2009, 14, 965–974.10.3851/IMP1399]Search in Google Scholar
[16. Klopfleisch R., Gruber A.D.: Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands. Res Vet Sci 2009, 87, 91–96.10.1016/j.rvsc.2008.12.010]Search in Google Scholar
[17. Lawrence D.: Quality control in molecular immunohistochemistry. Histochem Cell Biol 2008, 130, 473–480.10.1007/s00418-008-0481-0]Search in Google Scholar
[18. Lu H., Ouyang W., Huang C.: Inflammation, a key event in cancer development. Mol Cancer Res 2006, 4, 221–233.10.1158/1541-7786.MCR-05-0261]Search in Google Scholar
[19. Lukas W., Jones K.A.: Cortical neurons containing calretinin are selectively resistant to calcium overload and exitotoxicity in vitro. Neuroscience 1994, 61, 307–316.10.1016/0306-4522(94)90233-X]Search in Google Scholar
[20. Mariotti F., Giacomo R., Subeide M.: Immunohistochemical evaluation of ovarian hormonal receptors in canine mammary tumors. Open J Vet Med 2013, 3, 104–110.10.4236/ojvm.2013.32017]Search in Google Scholar
[21. Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., Woerner M., Edwards D.A., Flickinger A.G., Moore R.J., Seibert K.: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000, 60, 1306–1311.]Search in Google Scholar
[22. Milagres D., Rueff-Barroso C.R., Bolognese A.M., Costa A.M.A., Porto L.C.: Immunohistochemical localization of tumor necrosis factor-alpha and interleukin-6 during orthodontic movement in rats. Braz J Morphol Sci 2009, 26, 42–48.]Search in Google Scholar
[23. Miyoshi N., Tojo E., Oishi A., Fujiki M., Misumi K., Sakamoto H., Kameyama K., Shimizu T., Yasuda N.: Immunohistochemical detection of P-glycoprotein (PGP) and multidrug-resistance-associated protein (MRP) in canine cutaneous mast cell tumors. J Med Vet Sci 2002, 64, 531–533.10.1292/jvms.64.53112130841]Search in Google Scholar
[24. Muller W.A., Greene T., Liao F.: AS9. CD31 workshop panel report. In: Leucocyte typing VI. White cell differentiation antigens. Edited by Kishimoto T., Kikutani H., von dem Borne A.E.G., Goyert S.M., Mason D.Y., Miyasaka M., Moretta L., Okumura K., Shaw S., Springer T.A., Sugamura K., Zola H. Proc 6th International Workshop and Conference. Garland Publishing Inc., Kobe, Japan. New York, London 1996, pp. 362–364.]Search in Google Scholar
[25. Nollen E.A., Morimoto R.I.: Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci 2002, 115, 2809–2816.10.1242/jcs.115.14.280912082142]Search in Google Scholar
[26. Noseda M., Karsan A.: Notch and minichromosome maintenance (MCM) proteins: integration of two ancestral pathways in cell cycle control. Cell Cycle 2006, 5, 2704–2709.10.4161/cc.5.23.351517172856]Search in Google Scholar
[27. Nowińska K., Dzięgiel P.: The role of MCM proteins in cell proliferation and tumorigenesis. Postepy Hig Med Dosw 2010, 64, 627–635.]Search in Google Scholar
[28. Olsson M., Zhivotovsky B.: Caspases and cancer. Cell Death Differ 2011, 18, 1441–1449.10.1038/cdd.2011.30]Search in Google Scholar
[29. Painter J.T., Clayton N.P., Herbert R.A.: Useful Immunohistochemical markers of tumor differentiation. Toxicol Pathol 2010, 38, 131–141.10.1177/0192623309356449]Search in Google Scholar
[30. Paulin D., Li Z.: Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res 2004, 301, 1–7.10.1016/j.yexcr.2004.08.004]Search in Google Scholar
[31. Peña L.L., Nieto A.I., Pérez-Alenza D., Cuesta P., Castaño M.: Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. J Vet Diagn Invest 1998, 10, 237–246.10.1177/104063879801000303]Search in Google Scholar
[32. Perl A.K., Wilgenbus P., Dahl U., Semb H., Christofori G.: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998, 392; 190–193.10.1038/32433]Search in Google Scholar
[33. Pilozzi E., Pulford K., Jones M., Müller-Hermelink H.K., Falini B., Ralfkiaer E., Pileri S., Pezzella F., De Wolf-Peeters C., Arber D., Stein H., Mason D., Gatter K.: Co-expression of CD79a (JBC117) and CD3 by lymphoblastic lymphoma. J Pathol 1998, 186, 140–143.10.1002/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y]Search in Google Scholar
[34. Pusztaszeri M.P., Seelentag W., Bosman F.T.: Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand Factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006, 54, 385–395.10.1369/jhc.4A6514.2005]Search in Google Scholar
[35. Queiroga F.L., Perez-Alenza M.D., González-Gil A., Silván G., Peña L., Illera J.C.: Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA: clinical and prognostic implications. Vet Comp Oncol 2015, doi: 10.1111/vco.12174.10.1111/vco.12174]Search in Google Scholar
[36. Radi Z.A., Miller D.L.: Immunohistochemical expression of calretinin in canine testicular tumours and normal canine testicular tissue. Res Vet Sci 2005, 79, 125–129.10.1016/j.rvsc.2004.11.016]Search in Google Scholar
[37. Restucci B., Maiolino P., Martano M., Esposito G., De Filippis D., Borzacchiello G., Lo Muzio L.: Expression of β-Catenin, E-cadherin and APC in canine mammary tumors. Anticancer Res 2007, 27, 3083–3090.]Search in Google Scholar
[38. Rickers R.R., Malinisk R.M.: Intralaboratory quality assurance of immunohistochemical procedures: recommended practices for daily application. Arch Pathol Lab Med 1989, 113, 673–679.]Search in Google Scholar
[39. Taylor C.R., Shi S.R., Barr N.J.: Techniques of Immunohistochemistry: Principles, Pitfalls, and Standardization. In: Diagnostic Immunohistochemistry, edited by D. Dabbs, Saunders Elsevier, Pittsburgh, USA, 2006, pp. 1–41.]Search in Google Scholar
[40. Toniti W., Buranasinsup S., Kongcharoen A., Charoonrut P., Puchadapirom P., Kasorndorkbua C.: Immunohistochemical determination of estrogen and progesterone receptors in canine mammary tumors. Asian Pac J Cancer Prev 2009, 10, 907–911.]Search in Google Scholar
[41. Vaseva A.V., Moll U.M.: The mitochondrial p53 pathway. Biochim Biophys Acta 2009, 1787, 414–420.10.1016/j.bbabio.2008.10.005]Search in Google Scholar
[42. Webster J.D., Yuzbasiyan-Gurkan V., Kaneene J.B., Miller R.A., Resau J.H., Kiupel M.: The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia 2006, 8, 104–111.10.1593/neo.05622157851616611403]Search in Google Scholar
[43. Weng Y.R., Cui Y., Fang J.Y.: Biological functions of cytokeratin 18 in cancer. Mol Cancer Res 2012, 10, 485–493.10.1158/1541-7786.MCR-11-022222452884]Search in Google Scholar
[44. Werner M., Chott A., Fabiano A., Battifora H.: Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 2000, 24, 1016–1019.10.1097/00000478-200007000-0001410895825]Search in Google Scholar